| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/EHM.09.45 |
| P953 | full work available at URL | http://www.future-drugs.com/doi/abs/10.1586/ehm.09.45 |
| http://www.tandfonline.com/doi/pdf/10.1586/ehm.09.45 | ||
| P698 | PubMed publication ID | 21083022 |
| P50 | author | Sebastian E Illanes | Q91947025 |
| P2093 | author name string | Peter Soothill | |
| P2860 | cites work | Large-scale blood group genotyping - clinical implications | Q22242632 |
| Molecular cloning and primary structure of the human blood group RhD polypeptide | Q24294693 | ||
| Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound | Q28241617 | ||
| Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry | Q33317800 | ||
| Noninvasive fetal RhCE genotyping from maternal blood | Q33337785 | ||
| Fetal RhD genotyping from maternal plasma | Q33780684 | ||
| Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses | Q33885603 | ||
| Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma | Q34706395 | ||
| Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed | Q35043252 | ||
| Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. | Q35221979 | ||
| SAFE--the Special Non-invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements | Q37072636 | ||
| RHD genotyping from maternal plasma: guidelines and technical challenges | Q37143239 | ||
| Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
| Antenatal invasive therapy. | Q41700555 | ||
| Fetal RHD typing: Is fetal RHD typing in all RhD negative women cost effective? | Q43167634 | ||
| Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization | Q43677184 | ||
| Rh disease: intravascular fetal blood transfusion by cordocentesis. | Q45906338 | ||
| Fetal splenic size in anemia due to Rh-alloimmunization | Q47278900 | ||
| Reassuring fetal middle cerebral artery doppler velocimetry in alloimmunised pregnancies: neonatal outcomes without invasive procedures. | Q50757527 | ||
| Comparison of different reference values of fetal blood flow velocity in the middle cerebral artery for predicting fetal anemia. | Q50775076 | ||
| Doppler ultrasonography versus amniocentesis to predict fetal anemia. | Q53252870 | ||
| Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. | Q53426252 | ||
| Early detection of cell-free fetal DNA in maternal plasma. | Q53576548 | ||
| Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis. | Q53597278 | ||
| Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. | Q53786366 | ||
| The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. | Q54520641 | ||
| Workshop report on the extraction of foetal DNA from maternal plasma | Q56001878 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Prenatal Determination of Fetal RhD Type by DNA Amplification | Q57208591 | ||
| Doppler examination of the middle cerebral artery in anemic fetuses | Q68504166 | ||
| Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial | Q69001273 | ||
| Fetal liver length in normal and isoimmunized pregnancies | Q69519501 | ||
| The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization | Q69948479 | ||
| Percutaneous umbilical transfusion in severe rhesus isoimmunization: resolution of fetal hydrops | Q70372391 | ||
| Rh isoimmunization related to amniocentesis | Q70461346 | ||
| Dilation of the fetal umbilical vein in rhesus hemolytic anemia: a predictor of severe disease | Q70931232 | ||
| Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization | Q71727161 | ||
| The relationship between peak velocity in the fetal descending aorta and hematocrit in rhesus isoimmunization | Q72174281 | ||
| Fetal venous, arterial, and intracardiac blood flows in red blood cell isoimmunization | Q72357176 | ||
| Current management of the Rh-sensitized patient | Q72673107 | ||
| The use of ultrasonography and Doppler in the prediction of fetal haemolytic anaemia: a multivariate analysis | Q72772897 | ||
| A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix | Q73545154 | ||
| Increase of fetal hematocrit decreases the middle cerebral artery peak systolic velocity in pregnancies complicated by rhesus alloimmunization | Q73593752 | ||
| Middle cerebral artery Doppler for the prediction of fetal anaemia in cases without hydrops: a practical approach | Q74675597 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 577-582 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Expert Review of Hematology | Q15734429 |
| P1476 | title | Noninvasive approach for the management of hemolytic disease of the fetus | |
| P478 | volume | 2 |
| Q34426839 | Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy |
| Q43448023 | Costs and benefits of non-invasive fetal RhD determination |
| Q35674630 | Implementing non-invasive RHD genotyping on cell-free foetal DNA from maternal plasma: the Pavia experience |
| Q39170823 | Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome |
| Q37156646 | Management of haemolytic disease of the foetus & newborn: steps to improve the outcomes |
| Q35099257 | Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids |
| Q37306762 | Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation |
| Q43056215 | Non-invasive foetal RHD genotyping in transfusion medicine |
Search more.